Nkarta

Filed a patent for "dosing regimens for treatment of cancer" on Tue, June 27, 2023

Filed a patent for "methods for treatment using cd19-directed immunotherapies" on Tue, June 27, 2023

Filed a patent for "methods for treatment using cd19-directed immunotherapies" on Tue, August 29, 2023

Filed a patent for "dosing regimens for treatment of cancer" on Tue, August 29, 2023

Filed a patent for "methods for expanding immune cells and related compositions and uses thereof" on Wed, February 1, 2023

Filed a patent for "dosing regimens for combination therapies" on Mon, March 13, 2023

Filed a patent for "antibodies and chimeric antigen receptors specific for cd38" on Tue, March 28, 2023

Filed a patent for "dosing regimens for combination therapies" on Mon, May 1, 2023

Filed a patent for "dosing regimens for combination therapies" on Mon, June 26, 2023

Filed a patent for "dosing regimens for cancer immunotherapy" on Tue, November 7, 2023

Filed a patent for "methods for treatment of autoimmune diseases" on Fri, April 7, 2023

Filed a patent for "methods for treatment of autoimmune diseases" on Tue, June 27, 2023

Filed a patent for "methods for treatment of autoimmune diseases" on Fri, October 13, 2023

Filed a patent for "methods for treatment of autoimmune diseases" on Fri, January 5, 2024

Filed a patent for "methods for treatment of autoimmune diseases" on Wed, March 20, 2024

Filed a patent for "methods of engineering immune cells for enhanced potency and persistence and uses of engineered cells in immunotherapy" on Wed, May 31, 2023

Filed a patent for "dosing regimens for cd19-directed cancer immunotherapy" on Fri, July 1, 2022

Filed a patent for "genetic editing of target genes to enhance natural killer cell function" on Wed, August 3, 2022

Filed a patent for "selection of optimal cell donors and methods and compositions for enhanced expansion and cytotoxicity of donor cells" on Fri, October 21, 2022

Filed a patent for "dosing regimens for cd19-directed cancer immunotherapy" on Fri, October 21, 2022

Filed a patent for "dosing regimens for cd19-directed cancer immunotherapy" on Tue, November 8, 2022

Filed a patent for "enhanced expansion and cytotoxicity of engineered natural killer cells and uses thereof" on Thu, August 24, 2023

Filed a patent for "multiplex gene edited cells for cd70-directed cancer immunotherapy" on Thu, December 7, 2023

Filed a patent for "genetic editing of target genes to enhance natural killer cell function" on Mon, March 13, 2023

Filed a patent for "genetic editing of target genes to enhance natural killer cell function" on Tue, April 25, 2023